BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24777435)

  • 1. Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.
    Markar SR; Schmidt H; Kunz S; Bodnar A; Hubka M; Low DE
    J Gastrointest Surg; 2014 Jul; 18(7):1238-46. PubMed ID: 24777435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.
    Low DE; Kunz S; Schembre D; Otero H; Malpass T; Hsi A; Song G; Hinke R; Kozarek RA
    J Gastrointest Surg; 2007 Nov; 11(11):1395-402; discussion 1402. PubMed ID: 17763917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy.
    Depypere L; Thomas M; Moons J; Coosemans W; Lerut T; Prenen H; Haustermans K; Van Veer H; Nafteux P
    World J Surg Oncol; 2019 May; 17(1):89. PubMed ID: 31133018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
    Franko J; Voynov G; Goldman CD
    Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer.
    Rowse PG; Jaroszewski DE; Thomas M; Harold K; Harmsen WS; Shen KR
    Ann Thorac Surg; 2017 Oct; 104(4):1147-1152. PubMed ID: 28842111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
    Markar S; Gronnier C; Duhamel A; Pasquer A; Théreaux J; du Rieu MC; Lefevre JH; Turner K; Luc G; Mariette C
    J Clin Oncol; 2015 Nov; 33(33):3866-73. PubMed ID: 26195702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
    Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
    J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
    Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
    Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
    Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
    Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.
    Swanson SJ; Batirel HF; Bueno R; Jaklitsch MT; Lukanich JM; Allred E; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 2001 Dec; 72(6):1918-24; discussion 1924-5. PubMed ID: 11789772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Benchmarking Standards to Evaluate Transition to Minimally Invasive Esophagectomy.
    Carroll PA; Jacob N; Yeung JC; Darling GE
    Ann Thorac Surg; 2020 Feb; 109(2):383-388. PubMed ID: 31541632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma.
    Rice TW; Adelstein DJ; Chidel MA; Rybicki LA; DeCamp MM; Murthy SC; Blackstone EH
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1590-6. PubMed ID: 14666038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.
    Ji KSY; Thomas SM; Roman SA; Czito B; Anderson KL; Frakes J; Adam MA; Sosa JA; Robinson TJ
    J Gastrointest Surg; 2019 May; 23(5):885-894. PubMed ID: 30374818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
    Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
    Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
    Salem AI; Thau MR; Strom TJ; Abbott AM; Saeed N; Almhanna K; Hoffe SE; Shridhar R; Karl RC; Meredith KL
    Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27149640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Treatment of T1N0 Esophageal Cancer.
    Semenkovich TR; Hudson JL; Subramanian M; Mullady DK; Meyers BF; Puri V; Kozower BD
    Ann Surg; 2019 Sep; 270(3):434-443. PubMed ID: 31274653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of cervical esophageal cancer.
    Tong DK; Law S; Kwong DL; Wei WI; Ng RW; Wong KH
    World J Surg; 2011 Mar; 35(3):600-7. PubMed ID: 21161656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.